Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiri Ellenbogen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Gastroenterology|July 26, 2011
Iron and intestinal immunityBobby J Cherayil, Shiri Ellenbogen, Nandakumar N Shanmugam
Inflammatory Bowel Diseases|February 26, 2011
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel diseaseLijian Wang, Estela Trebicka, Ying Fu, et al.
Plos One|June 8, 2012
Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitisNanda Kumar N Shanmugam, Shiri Ellenbogen, Estela Trebicka, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|July 26, 2011
Iron and intestinal immunityBobby J Cherayil, Shiri Ellenbogen, Nandakumar N Shanmugam
Inflammatory Bowel Diseases|February 26, 2011
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel diseaseLijian Wang, Estela Trebicka, Ying Fu, et al.
Plos One|June 8, 2012
Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitisNanda Kumar N Shanmugam, Shiri Ellenbogen, Estela Trebicka, et al.
Pageof 1